Background: Spontaneous pneumothorax (SP) and pneumomediastinum (PM) have emerged as significant complications in patients with COVID-19, affecting both ventilated and non-ventilated individuals. These complications pose clinical management challenges, with surgical intervention often reserved for persistent or complicated cases. Objective: The objective of the study is to systematically review observational studies describing the incidence, clinical characteristics, and management strategies, with a focus on the role and timing of surgical intervention in COVID-19-associated SP and PM. Methods: We conducted a comprehensive literature search of PubMed, Embase, and Scopus from January 2020 to April 2025 for cohort and prospective studies reporting SP/PM in COVID-19 patients. Case reports and studies without management details were excluded. Data on demographics, clinical presentation, management, surgical indications, timing, and outcomes were extracted and analyzed. Results: Twelve observational studies, including 368 patients, were reviewed. SP occurred in 26%, PM in 19%, with 13% exhibiting both. Conservative management sufficed in 70% of cases, whereas 30% required chest tube drainage. Surgical intervention was performed in 16%, predominantly for persistent air leaks and recurrent pneumothorax. Video-assisted thoracoscopic surgery was the main surgical modality. Early surgical intervention (within 7 days) correlated with improved outcomes, including reduced hospital stay and lower recurrence rates. Conclusion: Surgical intervention plays a critical role in managing complicated SP and PM in COVID-19 patients. Early minimally invasive surgery is associated with better outcomes. Further prospective studies are necessary to optimize surgical timing and patient selection.
Pai et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: